1Bortoli A,Pedersen N,Duricova D. Pregnancy outcome in inflammatory bowel disease:prospective European case-control ECCO-EpiCom study,2003-2006[J].{H}Alimentary Pharmacology and Therapeutics,2011.724-734.
3Seinen ML,de Boer NK,van Hoorn ME. Safe use of allopurinol and low-dose mercaptopurine therapy during pregnancy in an ulcerative colitis patient[J].{H}Inflammatory Bowel Diseases,2013.E37.
4Kozenko M,Grynspan D,Oluyomi-Obi T. Potential teratogenic effects of allopurinol:a case report[J].{H}American Journal of Medicdl Genetics,2011.2247-2252.
5Argüelles-Arias F,Castro-Laria L,Barreiro-de Acosta M. Is safety infliximb during pregnancy in patients with inflammatory bowel disease[J].{H}Revista Espanola de Enfermedades Digestivas,2012.59464.
6Steenholdt C,Al-Khalaf M,Ainsworth MA. Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31[J].J Crohns Colitis,2012.358-361.
7Dozois EJ,Wolff BG,Tremaine WJ. Maternal and fetal outcome after colectomy for fulminant ulcerative colitis during pregnancy:case series and literature review[J].{H}Diseases of the Colon & Rectum,2006.64-73.
2Kombluth A,Sachar DB.Ulcerative colitis practice guide- lines in adults:American College of Gastroenterology,Prac- tice Parameters Committee[J].Am J Gastroenterol,2010,105(3):501-523.
3Molodecky NA,Soon IS,Rabi DM,et al.Increasing inci- dence and prevalence of the inflammatory bowel diseases with time,based on systematic review[J].Gastroenterology,2012,142(l):46-54.
